TY - CONF T1 - The addition of zoledronic acid to combination chemotherapy decreases circulating serum levels of vascular endothelial growth factor (VEGF) in early breast cancer JO - BONE PY - 2011/01/01 AU - Winter MC AU - Evans A AU - Holen I AU - Coleman RE ED - DO - DOI: 10.1016/j.bone.2010.10.082 VL - 48 IS - 1 SP - S30 EP - S31 Y2 - 2025/07/15 ER -